Sunday, November 15, 2026
18.4 C
Bengaluru

India’s Hospital Acquisitions Surge: RCML’s Pratiksha Deal Signals Expansion and Industry Trends

The healthcare sector in India has entered a dynamic phase of transformation, marked by record-breaking mergers and acquisitions (M&A) that are redefining national hospital networks, with increasing emphasis on pediatric, specialty, and regional expansion.

Spotlight: Rainbow Children’s Medicare Limited (RCML) Acquires Pratiksha Hospital

In August 2025, Hyderabad-based Rainbow Children’s Medicare Limited (RCML) announced its acquisition of a 76% controlling stake in Guwahati’s Pratiksha Hospital, valued at ₹171 crore. This all-cash transaction was fully funded via RCML’s reserves and internal accruals, expanding their network into Assam and the broader Northeast, and adding 150 beds to a national portfolio totaling 2,185 beds across 21 hospitals in eight cities[1][2][3][4][5].

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Evonile Pharma: The Real Bet Is Not the Acquisition. It is the Field Force.

ChrysCapital’s acquisition of Novartis India and its transformation into...

Closing the Value Gap in Indian Pharma: What Doctors Really Want from Digital Engagement

Indian pharma is investing heavily in digital engagement. But...

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...

Topics

Evonile Pharma: The Real Bet Is Not the Acquisition. It is the Field Force.

ChrysCapital’s acquisition of Novartis India and its transformation into...

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...

The Innovator’s Gene and the Generic’s Promise

A medicine must first be discovered. It must then...

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...
spot_img

Related Articles

spot_imgspot_img